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1. Introduction 
We describe a promising approach using in silico structure-function studies of protein 
atomic structure and computational medicine to understand disease. In silico studies use an 
atomic structure of proteins and molecular modeling for structure-function analysis. This 
approach is critical for large-scale genetic studies in order to understand a possible 
functional role of genetic mutations. Indeed, structural changes associated with missense 
mutations might impact protein folding, protein-protein interaction sites, or solubility or 
stability of protein molecules. The structural effect of mutational changes can be analyzed in 
silico on the basis of 3-dimensional structure, multiple alignments of homologous sequences, 
molecular modeling, and molecular dynamics simulations. The parameters derived from 3-
dimensional protein structure could be used in clinical studies to predict a severity of 
protein structure-function changes caused by genetic mutations and evaluate genotype-to-
phenotype relationships. In this chapter, we use X-linked retinoschisis (XLRS) as our disease 
model. XLRS is a form of juvenile macular and retinal degeneration in which schisis or 
splitting within the retinal layers leads to early and progressive vision loss. XLRS is a rare 
disease estimated to affect 1:5000 males (George et al., 1995; Wang et al., 2002) and is a 
disease with considerable clinical and electrophysiological variation. Precise analysis of 
XLRS is pertinent to identify disease severity and genotype-phenotype correlation. Due to 
the lack of a protein assay, a correlation between phenotype and genotype is difficult. 
Advances in molecular modeling give new insight to mutation severity at atomic level and 
provide a possible connection between genotype-phenotype correlations. This creates the 
hope that disease risk assessment at the atomic level will be a reality in the future. For our 
study, we use the electroretinogram (ERG) for our phenotypical data set, which we 
correlated with expected mutation severity. 
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2. Biological factors and electroretinography of XLRS 
2.1 Biology of retinoschisin protein: secretion and expression, hypothesized function, 
underlying mechanisms of functional loss of RS1 protein 
Retinoschisin (RS1) is a retinal secreted photoreceptor disulphide-linked oligomeric protein. 
A number of mutations in RS1 co-segregate with XLRS providing strong evidence that the 
disease is caused by mutations in the RS1 gene (Sauer et al., 1997). Although inherited 
mutations in the RS1 gene have been shown to cause an XLRS phenotype, the functional 
impact of most missense variants that result in a single amino acid change is less well 
defined. RS1 is a 24-kDa secreted protein which is expressed exclusively in the retina (Reid 
et al., 1999), pineal gland (Takada et al., 2006), and uterus (Huopaniemi et al., 1999). In 
retinal layers it is found in photoreceptor cells and in neurons of the inner retina (Figure 1). 
It encodes a conserved discoidin domain homologous to proteins involved in cell adhesion 
and cell–cell interactions. Based on its structural features, RS1 is believed to hold retinal cells 
together, to preserve the retinal architecture, and to function as an adhesive protein for the 
structural and functional integrity of the retina (Molday et al., 2007; Vijayasarathy et al., 
2007). It may mediate the association of the extracellular matrix with the surface of 
photoreceptors and other retinal cells to promote cell adhesion and thereby stabilize the 
cellular architecture of the highly structured retinal tissues. There exist three primary 
mechanisms that may be responsible for the loss of function of the RS1 protein: the 
misfolding of the discoidin domain, which negatively influences the putative adhesive 
properties of the protein; the defective disulfide-linked subunit assembly of RS1 into dimers 
and octamers; or the inability of RS1 to insert into endoplasmic reticulum membrane as part 
of the protein secretion process. 
 
 
Fig. 1. RS1 labeling in a wild-type mouse. Immunohistochemistry with antibody raised 
against RS1 protein. RS1 labeling in a normal adult C57BL/6J mouse retina, displayed by 
confocal microscopy, is observed in all retinal layers. On the right are shown RGCs: retinal 
ganglion cells, BCs: bipolar cells, ONL: outer nuclear layer, IS: inner segments, OS: outer 
segments.  
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2.2 Retinal morphology in retinoschisis: photoreceptors disruption and altered 
photoreceptor/bipolar cells synapse in the RS1-KO mouse 
Currently, there are three mouse models of human XLRS. One has been generated by 
homologus DNA insertion across the endogenous RS1 gene (Weber et al., 2002), presenting 
a phenotype consisting of abnormal retinal architecture with schisis in the inner nuclear 
layer, reduced outer segment layer thickness, loss of photoreceptors, and a selective ERG b-
wave reduction with relative sparing of the a-wave similar to XLRS male subjects. A second 
RS1 knock-out mouse model (Zeng et al., 2004) was created by substituting a neomycin 
resistance cassette for exon 1 and 1.6 kb in intron 1 of RS1h, the murine orthologue of the 
human RS1 gene. This model also displayed structural and functional features similar to 
those of human XLRS, including the electronegative ERG waveform and splitting in the 
inner nuclear layer similar to retinoschisis cavities by 6 months of age. They also 
demonstrated displacement of cells from the photoreceptor outer nuclear layer (ONL) and 
reduced thickness of the outer segment layer (Zeng et al., 2004). More recently, a third 
mouse model was generated using an ENU mutagenesis approach (Jablonski et al., 2005) 
derived from an induced mutation in intron 2 of RS1h, which leads to two novel splice 
variants. It is remarkable that, similar to the human condition, male homozygous mutant 
mice have retinal abnormalities as early as two weeks of age which do not appear to 
progress up to 38 weeks.  
2.3 Clinical features of XLRS disease: visual acuity, visual field, OCT, fundus 
appearance, ERG 
XLRS classical phenotype is present in two-thirds or more of affected males (George et al., 
1996) and consists in an early-onset central vision loss from bilateral foveo-macular cystic 
cavities involving the inner retina and additional retinal layers (Gregori et al., 2009) that 
extend from the fovea in a spoke-wheel pattern for approximately 1-1.5 disc diameter 
(Figure 2).  
XLRS patients often have hyperopic refractive error with astigmatism (Roesch et al., 1998; 
Kato et al., 2001; Vijayasarathy et al., 2009). Visual acuity ranging between 20/20 to 20/200 
in young patients, who come to ophthalmological attention because of reading difficulty, 
due to the macular involvement of the disease. Patients typically exhibit modest severity at a 
young age (cystic form), with a slow progression until the second decade, when most retain 
around 20/70 vision. It worsens through the teenage years and stabilizes in adulthood when 
the atrophic stage can lead to legal blindness (Lesch et al., 2008). However, some XLRS 
males exhibit unpredictable, severe disease even at very early age, and surprisingly, the 
ERG can show an unexpected preservation of the scotopic b-wave (Eksandh et al., 2005; 
Sieving et al., 1999a). 
XLRS is a highly penetrant disease condition (Forsius et al., 1973). In some cases subtle 
retinal changes are difficult to identify by ophthalmoscopy and can be detected only by 
optical coherence tomography (OCT) scans (Eriksson et al., 2004) (Figure 2). In the late 
stages of the disease when macular atrophy starts, a hyperfluorescent window defect of the 
retinal pigment epithelium (RPE) on fluoresceine angiography (FA) can be observed. This 
feature, however, can mimic retinal abnormalities seen in age-related macular degeneration 
or Stargardt maculopathy. In such cases, the combination of ERG, FA, and OCT is needed to 
determine the correct diagnosis. The electronegative scotopic ERG is pathognomonic of 
XLRS; the FA will not exhibit the dark choroid sign that is typically present in Stargardt’s 
maculopathy; and the OCT can detect cysts otherwise undetectable by standard 
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ophthalmoscopy. Peripheral retinoschisis can be found in half of affected males. Retinal 
splitting can involve all the retinal layers through the nerve fiber layer. The consequent 
abnormal visual signaling causes an dense scotoma in the involved areas (Li et al., 2007). 
Sometimes peripheral retinal scars, possibly to be considered pre-existing areas of self-
limited schisis, can be observed. 
 
 
Fig. 2. Collage of Prototypical Fundus (A, B, E, F), OCT (C, G) and ERG (D, H) in normal and 
in affected by XLRS individuals. Panels A-D and E-H correspond to the normal and the 
XLRS affected individuals, respectively. 
2.4 Photoreceptor and bipolar cell function as seen in the full field ERG 
The ERG is a useful tool for evaluate outer retinal function and may assist in identifying the 
primary sight of XLRS pathology. Through the interpretation of the ERG, one can pinpoint 
disease at the cellular level in outer retinal visual loss and monitor disease progression. The 
ERG is a good phenotypical measurement in wide spread disease due to its objective nature 
and ability to measure function of the entire retina. To better understand the pathology 
behind the characteristic electronegative ERG in XLRS, one must first understand normal 
retinal physiology. In a dark-adapted retina, free flowing ions move to and from the rod 
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photoreceptor. When rhodopsin in the rod photoreceptor captures a photon of light, it 
undergoes a conformational change causing a cascade of intracellular events within the 
photoreceptor outer segment resulting in hyperpolarization of the cell. Rod 
hyperpolarization causes an increased ionic potential towards the distal retina that results in 
the a-wave (Breton et al., 1994; Hagins et al., 1970). The rod then signals the on-bipolar cell 
which depolarizes and causes an influx of ions into the proximal retina. This forms the ERG 
b-wave. In XLRS, the b-wave amplitude is smaller than the a-wave amplitude (i.e. does not 
return to pre-flash baseline) and is deemed ‘electronegative’ (Figure 2H). An electronegative 
ERG suggests dysfunction proximal to the rod outer segment.  
2.5 Bipolar cell dysfunction and “electronegative” b-wave in both human and murine 
model of XLRS 
In the retina of the RS1-deficient mouse and the XLRS human the reduced scotopic ERG b-
wave amplitude (Figure 2H) suggests an effect on bipolar-cell function, perhaps initiated 
from an altered photoreceptor/bipolar-cell synapse activity. This implies primary 
involvement of the inner retina where schisis cavities occur in XLRS. The identification of L-
type voltage-gated calcium channels (Shi et al., 2009), Na/K ATPase (alpha3, beta2 isoforms) 
(Friedrich et al.), the sterile alpha and TIR motif-containing protein SARM1 (Molday, 2007), 
and phospholipids/Ca2+ (Vijayasarathy et al., 2007) as potential RS1 interacting ligands 
corroborate a role for RS1 in cell signaling events as well. However, ERG show considerable 
variation in this disease and ophthalmologists have to be aware about the possibility of 
relative ERG b-wave preservation especially in presence of atypical or mild manifestation of 
the disease (Eksandh et al., 2005; Sieving et al., 1999a; Vijayasarathy et al., 2009). These 
observations may imply that the degree of ERG dysfunctions may not correlate with the 
extent of fundus involvement and that synaptic integrity might be impaired secondarily 
over a greater extent of the fundus. In addition, because disruption of the inner segment 
architecture due to the loss of RS1 might be the basic mechanism that underlies the 
displacement and disorganization of photoreceptors in RS1-deficient mouse retina, reduced 
ERG a-wave responses can be found (Kjellstrom et al., 2007b). Clinically, abnormal 
photoreceptor function has been described in some XLRS subjects (Bradshaw et al., 1999; 
Kellner et al., 1990) mostly related to the advanced stages of the disease (Peachey et al., 1987) 
when the outer retinal atrophy may occur.  
2.6 The significance of phenotypic b/a-wave ratio  
In retina electrophysiology signal transmission between rod photoreceptors and the post-
synaptic bipolar cell neurons is measured by the amplitudes of the a-wave and b–wave, 
respectively (Newman and Odette, 1984; Robson and Frishman, 1995; Stockton and 
Slaughter, 1989). To account for any compromise of the photoreceptor layer in XLRS, a ratio 
of photoreceptor to bipolar-cell synaptic transmission compared to photo-transduction 
quality can be used: the b-wave amplitude to a-wave amplitude ratio (b/a-wave ratio). One 
can use the b/a-wave ratio to adjust for any photoreceptor dysfunction affect on the b-wave 
amplitude, and can imply the quantity of dysfunction in bipolar cells. Normally the b-wave 
amplitude is greater than the a-wave in the dark-adapted ERG for bright stimuli, but in 
XLRS the b-wave naturally is reduced (Peachey et al., 1987). Thus, a reduced b/a-wave ratio 
is characteristic of inner retinal disease such as XLRS.  
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2.7 Natural history and disease progression: role of age 
Several reports based on visual acuity loss (Apushkin et al., 2005), fundus changes with 
schisis cavities modification (Lesch et al., 2008), and retinal function deterioration 
(Vijayasarathy et al., 2010; Vijayasarathy et al., 2009) have focused on the “progressive” 
nature of XLRS disease. In detail, visual acuity is mostly impaired starting in grade school 
(Apushkin et al., 2005) due to macular schisis. However, even if 20% of XLRS children 
(Roesch et al., 1998) present significant vision loss in early childhood, half of these patients 
may have poor vision due to complications of the disorder, such as retinal detachment or 
vitreous hemorrhage. A bimodal age is a characteristic of presentation of XLRS in childhood 
(George et al., 1996). One group presented strabismus and nystagmus at an age less than 2 
years, and the other group presented only poor vision at approximately 7 years of age. 
Exotropia and esotropia were in the same proportion, and in the group with exotropia the 
occurrence of poor vision from severe schisis was highest. Rhegmatogenous (tractional 
retinal detachment) may also be the initial presentation of XLRS. Other XLRS males may 
present during infancy peripheral bullous elevation of the inner retinal layer accompanied 
with vitreous hemorrhage (George et al., 1996). In such cases it is difficult to assess a 
“progressive” trait of the disease.  
Retinal appearance at funduscopy, OCT scans and ERG b-wave amplitude reduction (Figure 
2, E-H) provide an estimate of the retinal changes in XLRS patients. A substantial change 
from the “cystic” (< 25 years old) to the “atrophic” (> 25 years old) pattern of the retina with 
age was recently described (Lesch et al., 2008). We also showed (Vijayasarathy et al., 2009) 
worsening of retinal function by age in a family harboring a null mutation in exon 5 of the 
RS1 gene indicating disease progression with age. In this study, the two younger males, 
ages 1.5 and 5 years, had well preserved b-waves extending above the pre-flash baseline and 
nearly normal ERG a-wave and b-wave configuration with a classical XLRS fundus 
appearance. However, four older affected male relatives, ages 32, 43, 43, and 48 years, 
showed the classic “electronegative” ERG with advanced XLRS retinal changes with 
reduced electronegative, b-waves. This suggests that older subjects had markedly decreased 
b-wave amplitudes compared to the younger subjects.  
In addition, disease progression has also been observed in natural history studies of the RS1 
knockout-mouse model (Kjellstrom et al., 2007b): progressive loss of photoreceptor nuclei 
and shortening of the outer segments with age has been found with a considerably 
reduction of the ERG a-wave amplitude by 16 months. An exact understanding of how 
XLRS disease progresses with age is not clear. In a recent study (Kjellstrom et al., 2010), 10 
XLRS subjects underwent baseline ERG testing between the ages of 6 and 15 years. Follow 
up ERG testing was preformed 8 to 14 years later. For the cohort, no difference was found 
either between the b-wave amplitude or b/a-wave ratio from the first to second visit. 
2.8 Clinical severity (metanalysis of severity grade systems) and genotype-phenotype 
correlation in human XLRS 
Wide phenotypic heterogeneity is one of the remarkable characteristic of this disease, and it 
is possibly related to the increasing number of mutations identified in the RS1 gene (1998). 
Currently, there is no standard method to grade the severity of XLRS disease. The clinical 
presentation of XLRS patients can vary based on the age of patients. Strabismus, nystagmus, 
hyperopia associated with severe cystic macular lesion with or without peripheral schisis, 
and subnormal ERG b-waves are findings more frequently reported at a very young age, 
while retinal detachment or progressive macular atrophy with or without peripheral retinal 
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scar, low visual acuity, and non-detectable ERG b-wave with reduced a-wave are instead 
mostly found in older ages. The OCT has been used to classify XLRS clinical severity. For 
example, clinical severity was determined by retinal examination and OCT scans in a cohort 
of 19 males, disregarding the genotype of the examined group (Prenner et al., 2006). Retinal 
tomography was more recently used (Lesch et al., 2008) to assess the prevalence of “cystic” 
and “atrophic” forms of the disease, variable with age. Visual acuity changes have been also 
considered valuable for predicting the extent of XLRS disease. However, Apushkin 
(Apushkin et al., 2005) analyzed the natural course of visual acuity changes in 38 XLRS 
patients, aged 9 to 65 years, finding only limited progression of vision loss over a mean 
follow-up period of 10 years. 
 Investigators have explored whether the type of mutations on the RS1 gene predict the 
severity of the disease. More than 160 mutations have been identified in the RS1 gene so far 
(1998). Mutations cause loss of protein function either due to the absolute loss of protein 
expression or to the presence of conformationally defective misfolded protein. The majority 
is missense mutations in exons 4–6; deletions, insertions, nonsense, and splice-site mutations 
have also been reported (Table 1). Several other studies have been conducted to ascertain 
correlations between genotype and phenotype in XLRS (Bradshaw et al., 1999; Eksandh et 
al., 2000a; Hiriyanna et al., 1999; Hotta et al., 2001; Lesch et al., 2008; Roesch et al., 1998; 
Shinoda et al., 2000; Sieving et al., 1999b); however, no clear link between genetic mutations 
and clinical phenotype have been firmly established. Furthermore, 145 unrelated XLRS 
families were examined in search of a correlation in severity of clinical phenotypes with the 
associated gene mutations (Hiriyanna et al., 1999). They found that mutations able to 
produce truncated RS1 protein (from deletions, splice-site and frame-shift mutations) are 
clearly related with severe phenotype. 
Moreover three Japanese XLRS patients were described with retinal detachment or severe 
macular lesion and low visual acuity at a very young age; two of them harbored deletions of 
exon 1 or of the boundary region between exon 3 and intron 3 (Shinoda et al., 2000). The 
authors also reported (Shinoda et al., 2004) a progressive XLRS phenotype in two siblings 
harboring a deletion of RS1 exon 4 and summarized that severe cases of XLRS are usually 
associated with upstream deletions (exons 1–3) in the RS1 gene which prevent the formation 
of functional mRNA (Hiriyanna et al., 1999; Shinoda et al., 2000), whereas the mild cases 
have relatively well preserved visual function and are usually associated with downstream 
deletions (exon 4). Two XLRS patients harboring “donor splice” mutation in exon 4, known 
to produce a null biochemical phenotype, with peripheral and central schisis, subnormal or 
non-detectable b-wave, and reduced a-wave, whereas another four patients, carrying 
missense mutations (R200C and R102W) resulted in more preserved ERG b-wave and 
almost normal retinal periphery with slight macular changes were reported (Bradshaw et 
al., 1999). We recently described (Vijayasarathy et al., 2010) a considerable difference 
between the severe clinical phenotype in subjects harboring RS1 null-protein signal-
sequence mutations and the less compromised retinal function in XLRS patients carrying 
missense mutation. These findings suggest that mutations, like deletions and frame shifts 
that putatively cause protein truncation, result in greater clinical severity of the disease, 
even if there is no univocal classification system for XLRS. All these mutations related to a 
partial or full loss of protein suggests a severe XLRS phenotype, and therefore, might be 
unified in a one group of non-missense severe variants (Table 1). 
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Mutations Noa DNA structure Protein structure Protein 
function 
Missense >110 Change a single 
nucleotide 
Code for a different 
amino acid 
Affects protein 
folding, sorting, 
loss of protein 
Nonsense 9 Codes for a stop codon Could truncate the 
protein 
Full or partial 
loss-of-function 
Splice site  16 A genetic mutation that 
inserts or deletes a 
number of nucleotides 
in the specific site at 
which splicing of an 
intron takes place 
during the processing of 
precursor messenger 
RNA into mature 
messenger RNA 
The abolishment of 
the splicing site 
results in one or more 
introns remaining in 
mature mRNA  
Production of 
aberrant 
proteins 
Deletions 26 Delete one or more 
nucleotides in DNA 
In-frame deletions or 
frameshifts 
Full or partial 
loss-of-function 
Insertions 4 Insert one or more 
nucleotides into DNA 
In-frame deletions or 
frameshifts 
Full or partial 
loss-of-function 
Silent  6 Change a single 
nucleotide 
Code for the same 
amino acid 
Native-like 
protein 
Table 1. Genetic mutations in X-linked retinoschisis and their role in protein 
structure/function. ahttp://www.retina-international.org/sci-news/xlrsmut.htm. 
3. Molecular modeling, functional role and severity of pathogenic mutations 
in human XLRS 
Genetic mutations often cause a change in protein expression. As described above several 
primary mechanisms might be responsible for the loss of RS1 function due to genetic 
mutations. The first mechanism is the misfolding of the discoidin domain, which changes 
the putative adhesive properties of the protein. Caused by missense mutations, RS1 
misfolding might initiate formation of aberrant proteins in non-native conformation. The 
second mechanism is the defective disulfide-linked subunit assembly of RS1 into dimers and 
octamers which results in abnormal protein secretion caused by missense changes affecting 
reactive thiol groups. The third mechanism is the inability of RS1 to insert into endoplasmic 
reticulum (ER) membrane as part of the protein secretion process. This is caused by severe 
changes associated with the insertion or the removal of large fragments in protein molecule, 
protein truncations, and null mutations.  
According to analysis in Paragraph 2.6 and Table 2 the majority of XLRS mutations could be 
divided in two large groups of (a) missense mutations and (b) non-missense changes with a 
severe XLRS phenotype. Although a severe role of non-missense changes is confirmed in 
numerous cases, the severity of XLRS phenotype for missense changes is less obvious. Here 
we imply molecular modeling of protein structure as described by ERGs clinical severities of 
XLRS via the computational evaluation of impact of pathogenic missense mutations.  
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3.1 Protein folding/misfolding in ER and protein folding landscapes 
The effect of missense mutations on a protein fold is difficult to understand without some 
basics of the native protein folding. Over one-third of newly synthesized proteins are 
translocated into the ER, which ensures their delivery into the secretory pathway. The ER 
lumen contains molecular chaperones that maintain polypeptide solubility, enzymes that 
are necessary for post-translational modification of proteins, and factors that directly assist 
in the folding of newly synthesized polypeptides such as foldases and isomerases. Proteins 
that not attain their native conformations, because of genetic mutations, cellular stress or 
other random events, may harm the cell. Therefore, protein systems within the ER lumen 
mediate quality control, that resulting in the resolution of terminally misfolded proteins 
from correctly folded proteins and folding intermediates. To compensate for the potentially 
disastrous consequences of misfolded protein accumulation, ER-retained species are most 
commonly destroyed.  
There are numerous observations of retinoschisins modified by missense mutations and 
expressed in cell culture which demonstrate the absence of modified RS1 bands from SDS-
PAGE or native gels and associated with a loss of protein due to misfolding and rapid 
degradation (Wang et al., 2002; Wang et al., 2006; Wu and Molday, 2003; Wu et al., 2005). 
Several major mechanisms lead to degradation of misfolded protein. About 30% of cytosolic 
proteins carry specific KFERQ-targeting motifs in their sequences allowing for selective 
targeting of cytosolic proteins to the lysosome for degradation by chaperone-mediated 
autophagy (Kaushik and Cuervo, 2006, 2008). However, the absence of the specific targeting 
motif in the RS1 sequence suggests another option. As a result, misfolded or unassembled 
proteins are retained in the ER bound to chaperones or lectins until they are delivered to the 
cytosol for degradation in the ubiquitin-proteasome pathway (Goldberg, 2003). Mutant 
variants with significant changes in protein fold caused by missense mutations or deletions 
could generate misfolded proteins susceptible to hydrolysis similar to that of human 
haemoglobin in which about one-fifth of missense proteins undergo rapid degradation 
(Goldberg, 2003). Therefore, the severe mutant variants are expected to have a markedly 
perturbed non-native protein fold causing misfolding in the ER and later digestion in the 
proteasome (Vijayasarathy et al., 2010).  
The mechanism by which a polypeptide chain folds to a specific three-dimensional protein 
structure was recently discussed (Dobson, 2004). In the ER, proteins fold into their native 
conformations and undergo different post-translational modifications and the formation of 
disulphide bonds. Native states of proteins almost always correspond to the structures that 
are most thermodynamically stable under physiological conditions. The primary sequence 
of protein is the major determinant for proper folding of protein (Anfinsen et al., 1961). The 
protein folds along several competing pathways into intermediate, non-native structures 
with decreasing free energies until it achieves a conformation with the lowest energy to 
form a protein with native interactions (Dobson, 2004). The total number of possible 
conformations of any polypeptide chain is so large that a systematic search for this 
particular structure would be impractical. The folding process involves a random search of 
many protein folds accessible to a polypeptide chain.  
The natural fluctuations in the conformation of an unfolded or incompletely folded 
polypeptide chain cause highly separated residues in the amino-acid sequence to come into 
contact with one other. In addition, if the energy surface of protein or ‘landscape’ has the 
correct shape, only a small number of all possible conformers needs to be tested by any 
given protein molecule during its transition from a random coil to a native structure. The 
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landscape is encoded by the amino-acid sequence of protein. Therefore, natural selection has 
enabled proteins to change so that polypeptides are able to fold rapidly and efficiently. Such 
a description is often referred to as the ‘new view’ of protein folding (Dobson, 1999, 2003, 
2004). On average, native-like interactions between residues are more determined and the 
polypeptide chain is finding lowest-energy structure by a process of trial and error. 
Misfolded or intermediate non-native proteins never achieve this lowest energy minimum. 
Pathogenic mutations produce a severe or mild effect in a protein structure and cause the 
protein to stay in an intermediate or even misfolded conformation with a relatively higher 
free energy.  
3.2 Role of cysteine residues and disulphide bonds in protein stability 
Cysteine residues normally form disulphide bonds which significantly constrain the number 
of possible conformers from finding a lowest-energy structure. The disulphide bond or 
disulphide bridge is formed by the pairing of two thiol groups of cysteines as a result of 
protein oxidation. A disulfide bond is a strong covalent bond of about 2.05 Å in length 
connecting two sulfur SǄ atoms which dissociate with energy of 60 kcal/mole. The structure 
of a disulfide bond can be described by its χss dihedral angle between the Cǃ − SǄ − SǄ − Cǃ 
atoms, which is in majority close to ±90°. When the dihedral angle approaches 0° or 180°, 
then the disulfide is a better oxidant. Rotation about the SǄ − SǄ axis has a low energy 
barrier.  
The disulfide bond holds two fragments of the protein chain together. This stabilizes the 
native fold of a protein by lowering entropy of the polypeptide chain and by condensing 
hydrophobic residues around the bond into local hydrophobic core using hydrophobic 
interactions. The disulfide bond increases the effective local concentration of hydrophobic 
residues causing a decrease of the local concentration of water molecules in the hydrophobic 
core. Since water molecules break up hydrogen bonds, their low concentration stabilizes a 
protein secondary structure.  
The native disulphide bonds are critical for proper protein folding. The native structure of a 
protein typically has a single disulfide bind. In proteins with more than two cysteines, non-
native disulfide species may be created. Non-disulphide species are almost always 
unfolded. As the number of cysteines increases, the number of non-native species increases 
significantly. Indeed, RS1 monomer has 10 cysteines which can form up to five disulphide 
bonds. In general, 10 cysteine residues can form 10C2=45 distinct disulphide bonds. A 
protein with ten-cysteines, such as RS1, could form 945 [=10!/(10/2)!210/2] different five-
disulfide species, only one of which is the protein with native disulfide bonds. All other 944 
proteins are the non-native disulphide species!  
In the cell in order to avoid non-native disulphides formation, protein disulphide 
isomerases (PDI) are necessary to catalyze the inter-conversion of disulfide species and 
accelerate the formation of the native disulfide species. In the ER, PDI has a function of a 
cellular chaperone with the essential foldase activity to maintain a native protein fold 
(Noiva, 1999; Tsai et al., 2001). PDI catalyzes oxidation and reshuffling (isomerization) of 
disulphides in substrate proteins by using the catalytic CxxC motif (Gruber et al., 2006). 
Current data suggest that PDI docks close to two SǄ cysteines in the substrate protein, forms 
a native disulphide bridge between those cysteines, and possibly stabilizes native contacts in 
that area by utilizing a chaperone function. Thus, we might conclude that PDI’s are an 
essential interaction partners of RS1 in ER in order to form a structure with native 
disulphide bonds. 
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Hence, we suggest that genetic mutations which are associated with the cysteine 
insertion/removal might interfere with suitable PDI binding in the vicinity of missense 
change. This might cause the appearance of new non-native disulphide bonds previously 
corrected by the foldase action. The insertion or deletion of cysteine residues should be 
taken into account when the severity of damage to protein molecule caused by the 
pathogenic missense change is evaluated. 
 
 
Fig. 3. A superposition of 3 discoidin ribbon structures to demonstrate the areas involved in 
interactions of discoidin domains with other molecules. Structures of the DDR2 discoinin 
domain bound to a triple-helical collagen peptide (magenta), the dimeric (cyan) and 
monomeric (white) forms of the membrane-binding C2 domain of human coagulation factor 
V (cyan) are shown.  
3.3 Discoidin domains and molecular modeling of RS1 protein structure 
Currently more than 72,000 protein structures have been determined by protein 
crystallography and deposited in the RCSB protein data bank. This list could be significantly 
expanded if structural genomic approaches such as a sequence homology and molecular 
modeling are used to generate protein structures. These computational methods were used 
successfully to predict the effect of thermodynamics experiments, to simulate the dynamics 
of protein folding and unfolding, and to explain a functional and structural role of elements 
of protein structure and other areas. 
Similar methods could be used to evaluate an impact of missense mutations on protein 
structure stability and function. We used molecular modeling to predict a structure of 
mature retinoschisin which is formed by Rs1 and discoidin domains (Sergeev et al., 2010). 
Discoidin domains have a similar fold with elements of spatial structure in a shape of a ǃ-
sandwich, shown schematically in Figure 3 (Baumgartner et al., 1998) as the superposition of 
three structures demonstrating a binding to different molecules. The galactose, 
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phospholipids, and collagen binding sites are located in shown in the lower part of this 
figure (area of spikes) suggesting a high conformational flexibility in this area (Carafoli et 
al., 2009; Macedo-Ribeiro et al., 1999). Moreover, the discoidin domains are able to form a 
dimeric structure shown by the cyan ribbon (Macedo-Ribeiro et al., 1999). Therefore binding 
to galactose, membrane, collagen, and a dimer formation could be potentially expected for 
the discoidin domain of retinoschisin. In general, the discoidin fold is conserved in more 
than 9 different proteins. The discoidin domain is present in single or multiple copies in 
extracellular or trans-membrane proteins implicated in cell-cell adhesion, and cell-cell 
interaction such as the coagulation factors V (FaV) and VIII (FaVIII), milk fat globule, 
neuropilin and neurexins, and implicated in phospholipid binding (Adams et al., 2004). In 
different species they have 47 highly conserved residues (~30% sequence identity) including 
2 cysteines forming a disulphide bridge and several tryptophans maintaining a stable 
hydrophobic core of a discoidin domain ǃ-sandwich (Kiedzierska et al., 2007). The structure 
of mature retinoschisin is shown in Figure 4A. In this structure the Rs1 domain is located in 
residues 25-64 and the folded, ǃ-sandwich discoidin domain occupies residues 65-224 (Wu 
and Molday, 2003). The structure of the mature retinoschisin was equilibrated using 
molecular dynamics (MD). Usually MD is used to obtain an ‘idealized’ or equilibrated 
protein structure with stereochemistry close to perfect. The main justification of the MD 
method is that statistical ensemble averages are equal to time averages of the system, so-
called the ergodic hypothesis. MD by computer simulation of physical movements by atoms 
and molecules take into account physical interactions between atoms of the protein 
structure and molecules of surrounding waters. Whereas it is possible to take "still 
snapshots" of crystal structures using X-Ray crystallography and NMR, no current 
experimental technique allows access to all the time scales of motion at atomic resolution.  
MD can be used to refine the location of cysteine residues in the RS1 structure which is 
necessary to understand retinoschisin function (Wang et al., 2002; Wang et al., 2006; Wu and 
Molday, 2003; Wu et al., 2005). The structure of mature RS1 contains 10 cysteines in 
positions 38, 40, 42, 59, 63, 83, 110, 142, 219, and 223, which are shared in an even proportion 
between Rs1 and discoidin domains (Figure 4A). The structure of the discoidin domain and 
the positions of 5 cysteines were reported in several cases (Fraternali et al., 2003; Wang et al., 
2006; Wu and Molday, 2003). The other 5 cysteines are located in the Rs1 domain of mature 
retinoschisin. In a protein structure, 7 cysteines are predicted to be concentrated in an area 
close to amino- and carboxy-termini, and 3 cysteines are located close to a spike area shown 
at the top (terminal extensions) and the bottom (discoidin domain) parts of Figure 4A, 
respectively. Nearly 70% of the RS1 surface is formed by non-polar groups (see Figures 4B 
and C, rotation of ~180o) suggesting that non-polar groups (green) could be important for 
the RS1 normal function. 
Although numerous experiments have demonstrated that retinoschisin is secreted as a 
monomer, dimer, or octamer in model cell systems (Wang et al., 2006; Wu et al., 2005) this 
protein is secreted in vivo as a homo-oligomeric complex. A structural model of secreted RS1 
homo-oligomeric protein complex currently is not available. Oligomerization is critical for 
the functioning of retinoschisin as an extracellular adhesion protein (Wu et al., 2005) where 
non-polar surface of RS1 could play a role. In contrast, protein misfolding caused by 
pathogenic mutation could interrupt proper secretion of a functional protein (Wang et al., 
2002; Wang et al., 2006; Wu and Molday, 2003). 
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Fig. 4. RS1 structure is a monomer with a significant fraction of non-polar surface. RS1 
structure is shown by a ribbon (Panel A). Positions of cysteines are shown in red. Accessible 
surface area of RS1 demonstrates a significant proportion of exposed non-polar areas shown 
by green (Panels B and C). 
3.4 Computational assessment of severity of protein damage caused by the 
pathogenic missense change 
in the last decade, new approaches using semi-empirical force-fields were developed in 
molecular modeling. Stability of native protein structure and protein complexes is defined 
by non-polar interactions, disulphide covalent bonds, salt bridges, and hydrogen bonds. 
Semi-empirical methods imply simplified forces and potentials are taken into account for 
these interactions within protein structure. Semi-empirical methods generate values of 
protein stabilization energies that correlate well with an experimental data for a majority of 
tested proteins. This approach might help to grade severities of molecular perturbations due 
to missense changes and explain how a genetic mutation could impact protein structure in 
quantitative manner. 
The free energy of protein stabilization (in kcal mol-1) is a function of several parameters. 
The first term includes a solvation energy contribution from hydrophobic and polar groups 
of protein (Eisenberg and McLachlan, 1986) based on a concept of accessible surface area 
(Lee and Richards, 1971) which could be evaluated using a fast geometry algorithm 
(Tsodikov et al., 2002). The second term is the energy of hydrogen bonds with regard to 
simple geometric considerations (Petukhov et al., 1999). Additional terms include Van der 
Waals energy which takes into account the experimental transfer energies from water to 
vapor; the electrostatic coulomb free energy term, which describes electrostatic interactions 
in protein; the crude entropy of protein chain to obtain a measure of free energy and free 
energy of the steric overlaps between atoms in protein structure (Abagyan and Totrov, 1994; 
Munoz and Serrano, 1994).  
Currently, all these terms are combined in the FoldX force field (Schymkowitz et al., 2005; 
Schymkowitz et al., 2002). The rapid evaluation of protein stabilization free energy change 
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due to missense mutations could be accessed with this field based on an empirical energy 
function derived from experimental work on proteins. The predictive power of this 
approach has been successfully tested with experimental thermodynamics data of 1000 
mutant proteins (Guerois et al., 2002) from the ProTherm database (Gromiha et al., 2000; 
Gromiha et al., 1999; Gromiha et al., 2002). Recently a combination of molecular dynamics 
folding simulations and FoldX potential has been suggested as an approach of in silico 
analysis of missense substitutions (Tavtigian et al., 2008). In our work, the changes in energy 
of protein stabilization due to missense change were evaluated using semi-empirical 
methods using the FoldX force field. 
In addition, we used information about differences between amino acids replacing each 
other in order to achieve a correct estimate for mutations involving cysteine residues. The 
amino acids differ by combination of several chemical factors like composition, polarity and 
molecular volume which correlate best with protein residue substitution frequencies as 
observed (Grantham, 1974). The Grantham difference for each amino acid pair could be 
used to characterize a physiochemical differences between wild-type and missense variant 
amino acid residues (Karchin et al., 2007; Tavtigian et al., 2008). 
Therefore, we suggested a molecular grading scale, so-called a computed impact score, CI 
(Sergeev et al., 2010), which considers changes in protein conformation and the Grantham 
differences between amino acids. Graphically, with these two categories as axes, the 
computed impact shows the characteristic distance between two amino acids involved in the 
mutation change. The axes are made orthogonal to facilitate the calculation of the difference 
in distance between amino acids. The overall difference, which is described by the CI, 
demonstrates the overall difference between two amino acids for the same position in wild-
type protein and mutant variant. The changes in energy of protein stabilization, ΔΔGstab, 
the CI, and accessible surface areas, ASA, were determined in our XLRS cohort, as shown in 
Table 2 for several mutations. Finally, the computed impact score used to grade an impact of 
each pathogenic mutation at the protein level was compared with severity of XLRS 
estimated from ERG data. 
 
Missense 
mutation 
ΔΔGstab, 
kcal/mol 
CI ASA, Ǻ2 Missense 
mutation 
ΔΔGstab, 
kcal/mol 
CI ASA, Ǻ2 
E72K 12.7 0.24 102 R141C 19.8 0.54 48 
W92C 20.7 0.61 209 N179D 21.6 0.36 8 
R102W 12.8 0.32 41 R200C 16.1 0.50 53 
L127P 27.7 0.50 6 R213W 12.6 0.32 0 
I136T 22.2 0.42 0 R213Q 10.6 0.20 0 
G140E 12.1 0.30 0 C219W 3.9 0.52 4 
Table 2. Computed impact, surface accessibility and protein stabilization energy change 
caused by the pathogenic missense mutations selected from our XLRS cohort. ASA is 
characterizing the residue exposure (>40 Ǻ2) or location in the protein hydrophobic core 
(≤40 Ǻ2). 
3.5 Molecular grading scale: protein structure-based classification of the pathogenic 
missense mutations impact in human XLRS  
We applied molecular modeling of the RS protein and consider perturbations caused by 
mutations found in human XLRS affected subjects. Computational analysis has predicted 
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that pathogenic missense mutations could be separated in two groups by using the 
molecular grading scale.  
The ERG b/a-wave ratios were sorted by patient age and by the impact of mutation on 
protein atomic structure. This analysis was applied independently to ERG b/a-wave ratios 
as a function of average patient age versus severity of XLRS phenotype (Figure 5A). To 
minimize the effect of statistical errors and to improve a signal-to-noise ratio in 
experimental ERG data, we used the method described previously (Sergeev et al., 2010) to a 
new XLRS cohort of patients. All b/a-wave ratios were divided into groups by age 
(younger, older) and by mutation severity (low-impact, high-impact) (Figure 5A). The b/a-
wave ratio in older (37-43 y/o) XLRS patients was greater than younger (13-17 y/o) for 
severe missense variants with the b-wave unchanged as the a-wave declined similarly to 
that observed in the Rs1b-KO mouse (Kjellstrom et al., 2007b) and in the NEI dataset 
(Sergeev et al., 2010). In the mouse model, the decline of a-wave amplitude with age 
coincided with the loss of outer nuclear layer cells, whereas the decline in the b-wave and 
the b/a-wave ratio was associated with increasing severity of schisis cavities in younger 
ages (Kjellstrom et al., 2007a). As result, phenotypic b/a-wave ratios declined for younger 
individuals accompanied by a corresponding rise of computed impact score, a measure of 
the structural severity of the mutation (Figure 5A). Although this change is statistically less 
significant for older patients, a common trend showing a slight decrease with computed 
impact seems to be similar to that of described for younger individuals.  
Differences in phenotypes were verified for low- and high-impact missense changes and 
severe non-missense mutations (Figure 5B). Low-impact missense changes show average 
b/a-wave ratio close to 1.0 for a maximum with 15 XLRS patients of different ages (labeled 
by star in bottom panel). This ratio corresponds to a maximum of 10 patients with an 
average value of approximately 0.6, which is consistent with more severe XLRS phenotype 
as expected for high-impact missense variants. In addition, the severity of high impact 
missense changes is confirmed by identical correspondence to 15 patients with the severe 
non-missense variants (top panel). Thus, low- and high-impact missense changes in protein 
structure might be associated with mild and severe changes in the XLRS phenotype. 
Earlier we demonstrated that maximum structure perturbations associated with severe 
XLRS phenotype arise from either the removal or insertion of cysteine residues or from 
changes in the hydrophobic core (Sergeev et al., 2010). Less severe or mild changes were 
associated with missense mutations targeting a significant part of protein surface. Our 
present study, which was uses different datasets, has demonstrated that mild phenotypic 
changes could be associated with mutations in the water inaccessible residues when polar-
to-polar or the hydrophobic-to-hydrophobic changes has appeared.  
Our computational analysis has predicted that pathogenic missense mutations could be 
separated in mild and severe groups of XLRS phenotype by using the molecular grading 
scale. The results for the expected phenotypes of 109 missense changes which are currently 
available for XLRS are shown in the Table 3. In order to understand how the phenotype of 
XLRS disease described by b/a-wave ratios is related to missense changes, we analyzed 
mutant residue accessibilities (ASA) in the RS1 structure similar to that of shown in the 
Table 2. All mutations were ranked according to their computed impact. These mutations 
were separated into two groups, low-impact and high-impact, by their computed severity 
threshold (~0.4) as previously demonstrated (Sergeev et al., 2010). From this analysis, half of 
the mild mutations could be considered as mutations which were partially or fully exposed 
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at the protein surface; another half are the mutations predicted to be buried in the 
hydrophobic core. Mutations from this latter group were variants related to insertion, 
exchange, or removal of charged residues or replacement with a homologous hydrophobic 
or polar residue. In only two cases, C223S and C83S, cysteines were affected by a mild 
missense change. In contrast, the majority of missense variants were predicted to cause 
severe changes, related to insertion or removal of cysteine residues (23 mutations) and/or 
buried in the hydrophobic core.  
 
 
 
 
 
Fig. 5. Severity of the XLRS phenotype is associated with the expected impact of missense 
changes on the RS1 protein structure. Panel A: ERG average b/a-wave ratios as a function 
of average patient age and severity of XLRS phenotype. Average b/a-wave ratios 
obtained for patients divided into 4 groups by missense mutations classes (low-impact, 
high-impact) and by patient age (young, old). Scotopic b/a-wave ratios for 4 groups of 
patients are shown. ERG b/a-wave ratios for right (RE) and left (LE) eyes in each group 
are black and shaded, respectively. Panel B: Histogram of the XLRS patient b/a-wave 
ratios divided in groups of a low- and a high-impact missense, and severe non-missense 
genetic mutations as predicted using by a molecular grading scale. No differences in age 
were considered in this case. Histograms bars with maximum counts are labeled by 
asterisks (*). The ratios were obtained for the same XLRS cohort of patients (< 55 years 
old). 
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XLRS 
phenotype 
 
 
Missense variants*) 
Mild  
 
R209H, D158N, R213Q, S73P, E146D, G70S, T185K, H207Q, I133F, A101P, 
R141H, E72K, G178D, E72D, Q154R, D168H, L113F, H207D, E72Q, E146K, 
G70A, A211T, G109A, R200H, R209L, E215Q, G109E, G140E, K167N, 
H222N, N104K, R141G, R102Q, R213W, R102W, P203L, T138A, P192A, 
A98E, G109R, C223S, W96R, P192T, I199T, P193L, R191P, C83S, A211F, 
P192S, R102E, E215K, D145H, P192R 
Severe  C59S, R197P, G70R, I195V, P192L, N179D, L69P, R197H, V76G, G74V, 
G135V, G140R, L137P, R209P, L216P, R209G, E72A, P193S, R156G, E215V, 
C219S, I136T, D143V, P68R, C142R, G109W, C110R, L103R, Y89C, F176S, 
C223R, C110Y, C219G, R209C, N99C, R200C, L127P, R197C, G70D, C219W, 
R182C, C219R, R141C, W163C, W122C, Y65C, W112C, Y155C, I81N, I81D, 
W92C, W96C, F108C, C142W, C223Y 
Table 3. Classes of XLRS phenotypes as predicted using the molecular grading scale for 110 
pathogenic missense variants. *) Human Gene Mutation, Retina News International, and X-
linked Retinoschisis Sequence Variation databases were used. 
Finally, this study confirms results of our previous work that severe phenotype maximum 
structure perturbations are related to dramatic changes in a protein hydrophobic core or to 
the deletion or insertion of cysteine residues affecting in general the stability of protein fold. 
The kinetics of the disease progression might depend on the degree of the mutation impact 
on protein stability caused by the pathogenic missense change. Thus, we have to incorporate 
age, genotype, and molecular modeling into ERG analysis to understand a functional role of 
pathogenic mutations.  
4. Incorporating age and genotype into ERG analysis 
In our study, the effect of high-impact missense mutations could be recognized as severe at 
an earlier age when compared to low-impact missense mutations. In order to recognize the 
predicted affect of mutations we look to kinetics of the disease progression and incorporate 
patient age into the analysis of the relationship between genotype and phenotype. An exact 
understanding of how XLRS disease progresses with age is not clear. A 15-year, longitudinal 
XLRS study suggests that XLRS is a more stationary disease up to age 35 years, as seen in 
baseline and follow up ERG testing of 10 subjects. The first examination was performed on 
subjects between 6 to 15 years of age. A follow up examination was preformed 8 to 14 years 
later. In both exams, all 10 subjects showed reduced b-wave amplitudes, and no difference 
was found between the b-wave amplitude of the first or second visit (Kjellstrom et al., 2010). 
With these studies in mind, we raised the question of what role XLRS mutation severity 
plays in the dark-adapted ERG response. We preformed a retrospective cross-sectional 
study on 73 XLRS subjects who were seen at the National Eye Institute between 2004 and 
2010. All subjects underwent ocular examination including a full-field ERG with ISCEV 
standard, dark-adapted response. All subjects were genotyped for RS1 mutations. By 
separating subjects into two mutation severity groups (low-impact, high-impact), our data 
suggest that null protein or severity dysfunctional protein is associated with more retinal 
dysfunction than mildly dysfunctional protein. Greater dysfunction of subjects with severe 
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mutations was seen in the b-wave amplitude and b/a-wave ratio (70.2 µV, p = 0.02, less 
severe = 54 eyes, more severe = 79 eyes; excluding those >55 y/o). In our XLRS cohort, 
subjects maintained a-wave amplitudes within normal limits, or slightly below normal 
limits, suggesting little to no change in photoreceptor number or function in older subjects 
compared to younger subjects. Also, mutation severity did not play a role in a-wave 
amplitude (more severe n = 44 subjects, less severe n = 30, difference =-2.29 µV, p=0.89, 
excluding those >55 y/o). This data suggest that the outer segment of the photoreceptor was 
only minimally affected at most, and that mutation burden lies at the level of the 
photoreceptor-to-bipolar cell synapse.  
Our cohort also displayed an earlier aging effect due to mutation than what would be 
expected from aging alone. The rise and fall of the b-wave amplitude with age in normal 
populations has been thoroughly studied (Birch and Anderson, 1992). At birth, the 
maximum response is minimal, but increases approximately 5 fold by age 4 months. By 5 
years of age, children have normal adult b-wave amplitudes. The b-wave was not 
statistically affected from 5 years to 55 years of age, showing less than 25 µV decline per 
decade. Between ages 45-55 and 55-65, a significant decline of approximately 100 µV b-wave 
amplitude was seen. Birch’s study showed that subjects ages 68 years have b-wave 
amplitudes approximately half those of subjects between the ages of 15 to 24 years. 
For some time, investigators have questioned the possibility of photoreceptor disease in 
XLRS. One study found decreased a-wave amplitudes in 1/3 of their XLRS cohort, 
suggesting that rod photoreceptor dysfunction or loss could be a more primary 
manifestation of XLRS that first thought (Bradshaw et al., 1999). However, the majority of 
studies suggest complete or relative preservation of the a-wave in XLRS (Eksandh et al., 
2000b; Kellner et al., 1990; Peachey et al., 1987). To look further into the question, Khan et al. 
modeled the leading edge of the a-wave to assess for pathology in the photo-transduction 
pathway (Khan et al., 2001). By modeling the first 15 ms of the waveform Khan found no 
difference between XLRS and normal subjects in sensitivity (S) and photoreceptor maximum 
amplitude (Kmax) in the majority of XLRS waveforms measured.  
4.1 The b/a-wave ratio can be a useful tool to quantify rod bipolar cell dysfunction 
relationship to rod function 
To account for any compromise of the photoreceptor layer in XLRS, a ratio of photoreceptor-
to-bipolar cell synaptic transmission compared to photo-transduction quality can be used 
(b/a-wave ratio). One can use the b/a-wave ratio to adjust for any photoreceptor 
dysfunction affect on the b-wave amplitude and can amplify the quantity of dysfunction in 
bipolar cells. 
A reduced b/a-ratio is a characteristic of XLRS. The clinical lower limit of normal for the b/a 
ratio is 1.2 (Sergeev et al., 2010). Given normal b-wave amplitudes previous discussed, one 
would expect preservation of b/a-ratios in normal subjects until approximately 55 years of 
age (Birch and Anderson, 1992). In our study, no change in b/a ratio was due to aging alone 
(n=143 eyes, difference = 0.0039/year, p=0.17; excluding those >55 y/o); however, subjects 
with low-impact mutations maintained an overall higher b/a-ratio up to 55 years of age 
than did subjects with high-impact mutations (difference 0.3, p = 0.005, less severe = 54 eyes, 
more severe = 79 eyes; excluding those >55 y/o; Figure 6).  
At first glance, it might appear that our study contradicts the XLRS longitudinal study by 
Kjellstrom (2010). However, had the longitudinal study identified the genetic mutations of 
all subjects (only three subjects were genotyped), a decrease in b/a-ratio could have been 
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expected in subjects with severe mutations. Of the three subjects who underwent 
genotyping, two had severe mutations and had decreased b/a-wave ratio at the follow up 
visit (ratios decreased from 1.2 to 0.8, and 1.1 to 0.77). According to our data, subjects with 
low-impact mutations would have only a modest change within the 10 to 15 year followup 
period. 
 
 
Fig. 6. Phenotypic data on clinical ERG b/a-wave ratios are shown for the cohort of X-linked 
retinoschisis patients as a function age (0-60 years old). Panel A: a superposition of ERG’s 
b/a-wave ratios for patients with severe non-missense and high-impact missense variants. 
Panel B: a superposition of ERG’s b/a-wave ratios for patients with the high-impact 
missense and low-impact missense variants. All data colored according to predicted 
severity: solid blue squares and green circles, solid black squares and red circles, open black 
squares and red circles are severe non-missense, high-impact missense and low-impact 
missense mutations. Squares and circles stand for right (OD) and left (OS) eye, respectively. 
The solid line and short dashes shows mean b/a-wave ratio and the mean minus two 
standard deviations, respectively, calculated from a group of 96 normal individuals (Sergeev 
et al., 2010). 
5. Conclusion 
Our computational analysis has suggested that the disease risk assessment at the atomic 
level could be implied in clinical studies. The combination of clinical electrophysiology, 
biology of retinal disease and molecular modeling provide a useful approach for evaluation 
of possible associations between the predicted structural alteration and/or damage to 
retinoschisin and the severity of XLRS disease.  
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